HW&C
HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
201
FibroGen
FGEN
$48.9M
|
MK
Matthew Keller
| $12.10 | $43 |
255%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
202
Arvinas
ARVN
$575M
|
ASF
Andrew S. Fein
| $7.83 | $18 |
130%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
203
Structure Therapeutics
GPCR
$1.27B
|
AG
Ananda Ghosh
| $22.08 | $60 |
172%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
204
Rhythm Pharmaceuticals
RYTM
$6.78B
|
RS
Raghuram Selvaraju
| $102.12 | $100 |
2%
downside
| Buy |
7 Aug ‘25
1 month ago |
|
205
CRISPR Therapeutics
CRSP
$4.99B
|
MK
Mitchell Kapoor
| $54.86 | $80 |
46%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
206
Mirum Pharmaceuticals
MIRM
$3.82B
|
SR
Swayampakula Ramakanth
| $76.06 | $80 |
5%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
207
Delcath Systems
DCTH
$408M
|
SR
Swayampakula Ramakanth
| $11.65 | $31 |
166%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
208
Sagimet Biosciences
SGMT
$231M
|
BF
Brandon Folkes
| $7.11 | $29 |
308%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
209
LifeMD
LFMD
$287M
|
YC
Yi Chen
| $6.06 | $13 |
115%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
210
Alnylam Pharmaceuticals
ALNY
$59.2B
|
PT
Patrick Trucchio
| $452 | $570 |
26%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
211
Context Therapeutics
CNTX
$73.6M
|
EB
Emily Bodnar
| $0.8204 | $4 |
388%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
212
Hecla Mining
HL
$6.04B
|
HI
Heiko Ihle
| $9.02 | $12.50 |
39%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
213
Gold Royalty Corp
GROY
$656M
|
HFI
Heiko F. Ihle
| $3.84 | $6.25 |
63%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
214
Gold Resource Corp
GORO
$103M
|
HFI
Heiko F. Ihle
| $0.7530 | $1.25 |
66%
upside
| Buy |
6 Aug ‘25
1 month ago |
|
215
EyePoint Pharmaceuticals
EYPT
$966M
|
YC
Yi Chen
| $14.01 | $23 |
64%
upside
| Buy |
6 Aug ‘25
1 month ago |
|
216
Personalis
PSNL
$465M
|
SR
Swayampakula Ramakanth
| $5.24 | $8.50 |
62%
upside
| Buy |
6 Aug ‘25
1 month ago |
|
217
Y-mAbs Therapeutics
YMAB
$390M
|
RB
Robert Burns
| $8.58 | $8.60 |
0%
upside
| Neutral |
6 Aug ‘25
1 month ago |
|
218
Cogent Biosciences
COGT
$1.82B
|
RB
Robert Burns
| $13.05 | $21 |
61%
upside
| Buy |
6 Aug ‘25
1 month ago |
|
219
Cardiff Oncology
CRDF
$144M
|
RB
Robert Burns
| $2.17 | $10 |
361%
upside
| Buy |
6 Aug ‘25
1 month ago |
|
220
Halozyme
HALO
$8.76B
|
MK
Mitchell Kapoor
| $74.93 | $75 |
0%
upside
| Buy |
6 Aug ‘25
1 month ago |
|
221
Day One Biopharmaceuticals
DAWN
$773M
|
ASF
Andrew S. Fein
| $7.55 | $25 |
231%
upside
| Buy |
6 Aug ‘25
1 month ago |
|
|
RAPP
222
Rapport Therapeutics
RAPP
$524M
|
DT
Douglas Tsao
| $14.36 | $31 |
116%
upside
| Buy |
6 Aug ‘25
1 month ago |
|
223
Evolus
EOLS
$495M
|
DT
Douglas Tsao
| $7.66 | $20 |
161%
upside
| Buy |
6 Aug ‘25
1 month ago |
|
224
Indivior
INDV
$3.12B
|
BF
Brandon Folkes
| $24.98 | $28 |
12%
upside
| Buy |
6 Aug ‘25
1 month ago |
|
225
Uranium Energy
UEC
$4.96B
|
HFI
Heiko F. Ihle
| $11.17 | $12.75 |
14%
upside
| Buy |
6 Aug ‘25
1 month ago |
|